150 related articles for article (PubMed ID: 37906918)
1. [Cryoglobulinemic vasculitis due to hyperviscosity and cryogel formation as the onset of multiple myeloma. Report of one case].
Arratia G; San-Martín F; Brkljaca N; Agüero C; Vergara M; Guzmán AM
Rev Med Chil; 2022 Jun; 150(6):832-835. PubMed ID: 37906918
[TBL] [Abstract][Full Text] [Related]
2. Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone.
Kikuchi R; Onozawa M; Nagai J; Okada S; Hasegawa Y; Ohigashi H; Mitamura S; Maeda T; Takakuwa E; Fujieda Y; Goto H; Hashimoto D; Matsuno Y; Teshima T
Intern Med; 2024 Feb; 63(4):541-545. PubMed ID: 37316269
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
4. [Cryoglobulinemia in a case of multiple myeloma associated with viral hepatitis B].
Stuklov NI; Chistiakova AV; Semenova EN; Zagrebneva AI; Shakhnovskaia NP; Variasin VV; Zhukova ME; Cherkashina IV; Ushakova OV
Klin Med (Mosk); 2014; 92(1):50-6. PubMed ID: 25265660
[TBL] [Abstract][Full Text] [Related]
5. Concomitant cryoglobulinemic vasculitis and cold agglutinin disease successfully treated with bortezomib: A case report.
Liu XH; Liu MX; Jin F; Zhang M; Zhang L
Medicine (Baltimore); 2019 Jan; 98(4):e14201. PubMed ID: 30681592
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Type 1 Cryoglobulinemic Vasculitis With Cardiac Involvement.
Cao XX; Tian Z; Lin L; Sun J; Su W; Zhou DB; Li J
Can J Cardiol; 2018 Mar; 34(3):343.e1-343.e3. PubMed ID: 29395708
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
8. Cryoglobulinemic vasculitis: pathophysiological mechanisms and diagnosis.
Kolopp-Sarda MN; Miossec P
Curr Opin Rheumatol; 2021 Jan; 33(1):1-7. PubMed ID: 33186245
[TBL] [Abstract][Full Text] [Related]
9. [Cryoglobulins and cryoglobulinemic vasculitis].
Suszek D; Majdan M
Wiad Lek; 2018; 71(1 pt 1):59-63. PubMed ID: 29558353
[TBL] [Abstract][Full Text] [Related]
10. Cryoglobulinemic disease.
Retamozo S; Brito-Zerón P; Bosch X; Stone JH; Ramos-Casals M
Oncology (Williston Park); 2013 Nov; 27(11):1098-1105, 1110-6. PubMed ID: 24575538
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
12. Heat insoluble cryoglobulin associated with gangrene in multiple myeloma.
Modarressi A; Kuriyan M; Harvey G; Strair R
J Clin Apher; 2003; 18(4):190-3. PubMed ID: 14699596
[TBL] [Abstract][Full Text] [Related]
13. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.
Besada E; Vik A; Koldingsnes W; Nossent JC
Int J Hematol; 2013 Jun; 97(6):800-3. PubMed ID: 23616220
[TBL] [Abstract][Full Text] [Related]
15. Cryoglobulinemia manifested by gangraene of almost all fingers and toes.
Vacula I; Ambrózy E; Makovník M; Stvrtina S; Babál P; Stvrtinová V
Int Angiol; 2010 Dec; 29(6):560-4. PubMed ID: 21173736
[TBL] [Abstract][Full Text] [Related]
16. Cryoglobulins and pyroglobulins: an overview.
Dammacco F; Miglietta A; Lobreglio G; Bonomo L
Ric Clin Lab; 1986; 16(2):247-67. PubMed ID: 3097789
[TBL] [Abstract][Full Text] [Related]
17. [Renal involvement during type 1 cryoglobulinemia].
Zaidan M; Plasse F; Rabant M; Javaugue V; Knebelmann B; Alyanakian MA; Joly D; Nochy D; Bridoux F
Nephrol Ther; 2016 Apr; 12 Suppl 1():S71-81. PubMed ID: 26972092
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib in type I cryoglobulinemic vasculitis: are we acting too late?
Ramirez GA; Campochiaro C; Salmaggi C; Pagliula G; D'Aliberti T; Marcatti M; Tresoldi M; Praderio L
Intern Med; 2015; 54(9):1119-23. PubMed ID: 25948361
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy].
Delyon J; Bezier M; Cordoliani F; Malphettes M; Szalat R; Bagot M; Rybojad M
Ann Dermatol Venereol; 2013 Jan; 140(1):30-5. PubMed ID: 23328357
[TBL] [Abstract][Full Text] [Related]
20. Intravascular crystal deposition: an early clue to the diagnosis of type 1 cryoglobulinemic vasculitis.
Gammon B; Longmire M; DeClerck B
Am J Dermatopathol; 2014 Sep; 36(9):751-5. PubMed ID: 25147987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
